Mangalam Drugs And Organics Limited (MANGALAM) — share transfer | 13 July 2026

StockFin.ai

Try Free

📢 Key Event
Compliance certificate issued for Q1 2026 securities dematerialization

💡 Investor Takeaway
The company confirms routine regulatory compliance with no material impact on operations or financials.

Mangalam Drugs and Organics Limited received a compliance certificate from MUFG Intime India Private Limited, its share transfer agent, confirming dematerialization of securities for the quarter ended June 30, 2026, in line with SEBI regulations. The filing covers the reporting period, pending and resolved transfers, and confirms procedural compliance without material changes or future guidance.

📄 View Original Announcement (PDF)

📊 Stock Analysis — MANGALAM ✨ Ask AI About This

About Mangalam Drugs And Organics Limited (MANGALAM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

View full MANGALAM stock details →

📡 Get AI alerts when MANGALAM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANGALAM — Free

💡 Ask AI about this filing

"How does this affect MANGALAM margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More MANGALAM filings

See all MANGALAM filings →

🔥 Also filed on 13 July 2026

MIRZAINT Mirza International Limited Insider Trading APTUS Aptus Value Housing Finance India Limited Annual Report SBILIFE SBI Life Insurance Company Limited Announcement IMFA Indian Metals & Ferro Alloys Limited Annual Report JUBLINGREA Jubilant Ingrevia Limited Financial Results POCL Pondy Oxides & Chemicals Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when MANGALAM files new disclosures

Track MANGALAM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MANGALAM — Free

Free account · 2 AI queries/day